Rockville, MD · Founded 2020 · Privately Held (backing)
Developer of a precision oncology platform designed to support the development of targeted therapies for hard-to-treat cancers. Clasp Therapeutics is based in Rockville, MD and was founded in 2020. Its last reported valuation was $192 million in Dec 2023. It has raised $150 million.
Last reported valuation
$191.5M
Oct 2026
Priced at
—
Total raised
$150.0M
Last round
—
Cap table — not yet on record
Clasp Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Clasp Therapeutics with a free account
·The complete investor list: 16 names
·Watch Clasp Therapeutics: the Monday email on marks, rounds and moves
